• 佛跳墙vp最新版2025极光

    Uniting stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine

    Learn moreStrategic Plan
    Diagram of the plan

A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

赛·风4 for android

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

佛跳墙vp最新版2025极光

佛跳墙vp最新版2025极光

/in News /by

With over 600 virtual sessions and events, AIDS 2025: Virtual will enable delegates to access and engage with the latest HIV science, advocacy and knowledge traditionally presented at the conference, while offering a range of new features made possible by the new virtual format. Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Download the HIV vaccine, and vaccine research roadmap.

Read more

佛跳墙vp最新版2025极光

佛跳墙vp最新版2025极光

/in Events /by

This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Read more

佛跳墙vp最新版2025极光

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.
Submit a timely topic

佛跳墙vp最新版2025极光

C. Bickel, Science Translational Medicine; National Institute of Allergy and Infectious Diseases

佛跳墙vp最新版2025极光

Book case (illustration)

佛跳墙vp最新版2025极光

African children (illustration)

2nd Infant Trials Workshop

賽风官网下载

Knowns and Unknowns of Assaying ADCC against HIV

佛跳墙vp最新版2025极光

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

© Copyright - The Global HIV Vaccine Enterprise - Enfold Theme by Kriesi
Scroll to top
WP Twitter Auto Publish Powered By : XYZScripts.com
    • outline破解版,outline官网网址,outline7天试用,outlinevn  橘子云破解版,橘子云ios下载,橘子云免费永久加速,橘子云vn  Ensoleillé官网网址,Ensoleillé2025年,Ensoleillé不能用了,Ensoleillévp  狗急加速器破解版,狗急加速器7天试用,狗急加速器用不了了,狗急加速器vp  shadowrocket加速器官网,shadowrocket加速器mac下载,shadowrocket加速器打不开,shadowrocket加速器不能用了  烧饼哥加速器ios下载,烧饼哥加速器免费永久加速,烧饼哥加速器2025,烧饼哥加速器vps